Proellex-V telapristone: Phase IIb started

Repros began a double-blind, placebo-controlled Phase IIb trial to evaluate 6 and 12 mg Proellex vaginal suppository in 18-week courses for up to 2 courses in about 45 premenopausal woman. The course...